We are analyzing https://link.springer.com/article/10.1186/1475-2891-12-118.

Title:
The relationship between baseline nutritional status with subsequent parenteral nutrition and clinical outcomes in cancer patients undergoing hyperthermic intraperitoneal chemotherapy | Nutrition Journal
Description:
Background The combination of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is a promising treatment option for selected patients with peritoneal carcinomatosis. This retrospective study investigated the relationship between baseline nutritional assessment with subsequent parenteral nutritional (PN) and clinical outcomes in cancer patients undergoing CRS and HIPEC. Methods A consecutive series of 60 patients undergoing CRS and HIPEC at our institution between January 2009 and May 2011. Subjective Global Assessment (SGA) was used to assess nutritional status. Patients were classified preoperatively as: well nourished (SGA-A), mildly-moderately malnourished (SGA-B), and severely malnourished (SGA-C). For PN, patients were divided into 2 groups: those who received PN (PN+) and those who did not receive PN (PN-). The primary outcomes of interest were length of stay (LOS), postoperative complications, ECOG performance status (PS) and survival. LOS was calculated as the number of days in the hospital post surgery. Performance status was measured on a scale of 0-4. Survival was calculated from the date of first visit to the date of death/last contact. Results Of 60 patients, 19 were males and 41 females. The mean age at presentation was 50.3 years. The most common cancer types were colorectal (n = 24) and gynecologic (n = 19) with the majority of patients (n = 47) treated previously before coming to our institution. 33 patients were SGA-A, 22 SGA-B and 5 SGA-C prior to surgery. Of a total of 60 patients, 31 received PN. Mean LOS for the entire cohort was 16.2 days (SD = 9.8). Mean LOS for preoperative SGA-A, SGA-B and SGA-C were 15.0, 15.2 and 27.8 days respectively (ANOVA p = 0.02). Overall incidence of complications was 26.7% (16/60). Complications were recorded in 9 of 33 (27.3%) preoperative SGA-A patients and 7 of 27 (25.9%) SGA-B + C patients (p = 0.91). The median overall survival was 17.5 months (95% CI = 13.0 to 22.1 months). Median survival for preoperative SGA-A and SGA-B + C cohorts was 22.4 and 10.4 months respectively (p = 0.006). Conclusions The preoperative SGA predicts LOS and survival in cancer patients undergoing HIPEC. Future randomized clinical trials in this patient population should investigate the systematic provision of PN to all malnourished patients in the preoperative period for a minimum of 7-10 days with the continuation of PN in the postoperative period.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't figure out the monetization strategy.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Link.springer.com might be cashing in, but we can't detect the method they're using.

Keywords {🔍}

patients, nutritional, article, cancer, pubmed, google, scholar, status, survival, assessment, nutrition, peritoneal, sga, los, surgery, hipec, group, carcinomatosis, preoperative, chemotherapy, study, complications, cas, data, clinical, crs, groups, intraperitoneal, patient, outcomes, hyperthermic, postoperative, subjective, days, baseline, treatment, parenteral, global, oncol, analysis, undergoing, cytoreductive, months, surg, sgaa, malnourished, colorectal, treated, gupta, sgab,

Topics {✒️}

open access article article download pdf hyperthermic intraperitoneal chemotherapy intraperitoneal hyperthermic chemotherapy alternative nutrition-assessment technique independent sample t-test perioperative intraperitoneal chemotherapy subjective global assessment long-term survivors small sample size privacy choices/manage cookies full access subjective nutritional assessment common surgery-related complications authors’ original file epithelial ovarian cancer anticancer therapy baseline nutritional assessment chemotherapy-related complications depth nutritional assessment timely nutritional assessment subsequent parenteral nutrition supplementary parenteral nutrition nutritional status assessment future research cancer treatment centers subsequent parenteral nutritional post-operative periods systemic chemotherapy intraperitoneal chemotherapy common cancer types deep vein thrombosis histologically confirmed diagnosis baseball stitch fashion primary independent variables kaplan-meier method major surgical procedure peritoneal malignancy program peritoneal surface malignancy o'connor mp nephrol dial transplant subhasis misra & komen journal finder publish advanced stage disease peritoneal carcinomatosis arising peritoneal carcinomatosis index previously treated disease provide nutrition support perioperative nutrition support baseline nutritional status

Questions {❓}

Chua TC, Yan TD, Saxena A, Morris DL: Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?
Detsky AS, McLaughlin JR, Baker JP, Johnston N, Whittaker S, Mendelson RA, et al: What is subjective global assessment of nutritional status?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:The relationship between baseline nutritional status with subsequent parenteral nutrition and clinical outcomes in cancer patients undergoing hyperthermic intraperitoneal chemotherapy
         description:The combination of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is a promising treatment option for selected patients with peritoneal carcinomatosis. This retrospective study investigated the relationship between baseline nutritional assessment with subsequent parenteral nutritional (PN) and clinical outcomes in cancer patients undergoing CRS and HIPEC. A consecutive series of 60 patients undergoing CRS and HIPEC at our institution between January 2009 and May 2011. Subjective Global Assessment (SGA) was used to assess nutritional status. Patients were classified preoperatively as: well nourished (SGA-A), mildly-moderately malnourished (SGA-B), and severely malnourished (SGA-C). For PN, patients were divided into 2 groups: those who received PN (PN+) and those who did not receive PN (PN-). The primary outcomes of interest were length of stay (LOS), postoperative complications, ECOG performance status (PS) and survival. LOS was calculated as the number of days in the hospital post surgery. Performance status was measured on a scale of 0-4. Survival was calculated from the date of first visit to the date of death/last contact. Of 60 patients, 19 were males and 41 females. The mean age at presentation was 50.3 years. The most common cancer types were colorectal (n = 24) and gynecologic (n = 19) with the majority of patients (n = 47) treated previously before coming to our institution. 33 patients were SGA-A, 22 SGA-B and 5 SGA-C prior to surgery. Of a total of 60 patients, 31 received PN. Mean LOS for the entire cohort was 16.2 days (SD = 9.8). Mean LOS for preoperative SGA-A, SGA-B and SGA-C were 15.0, 15.2 and 27.8 days respectively (ANOVA p = 0.02). Overall incidence of complications was 26.7% (16/60). Complications were recorded in 9 of 33 (27.3%) preoperative SGA-A patients and 7 of 27 (25.9%) SGA-B + C patients (p = 0.91). The median overall survival was 17.5 months (95% CI = 13.0 to 22.1 months). Median survival for preoperative SGA-A and SGA-B + C cohorts was 22.4 and 10.4 months respectively (p = 0.006). The preoperative SGA predicts LOS and survival in cancer patients undergoing HIPEC. Future randomized clinical trials in this patient population should investigate the systematic provision of PN to all malnourished patients in the preoperative period for a minimum of 7-10 days with the continuation of PN in the postoperative period.
         datePublished:2013-08-14T00:00:00Z
         dateModified:2013-08-14T00:00:00Z
         pageStart:1
         pageEnd:8
         license:https://creativecommons.org/licenses/by/2.0
         sameAs:https://doi.org/10.1186/1475-2891-12-118
         keywords:
            Parenteral Nutritional
            Peritoneal Carcinomatosis
            Nutritional Assessment
            Subjective Global Assessment
            Hyperthermic Intraperitoneal Chemotherapy
            Clinical Nutrition
            Health Promotion and Disease Prevention
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1475-2891-12-118/MediaObjects/12937_2013_Article_693_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1475-2891-12-118/MediaObjects/12937_2013_Article_693_Fig2_HTML.jpg
         isPartOf:
            name:Nutrition Journal
            issn:
               1475-2891
            volumeNumber:12
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Pankaj G Vashi
               affiliation:
                     name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center
                     address:
                        name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center, Zion, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Digant Gupta
               affiliation:
                     name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center
                     address:
                        name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center, Zion, USA
                        type:PostalAddress
                     type:Organization
                     name:Cancer Treatment Centers of America®
                     address:
                        name:Cancer Treatment Centers of America®, Schaumburg, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Carolyn A Lammersfeld
               affiliation:
                     name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center
                     address:
                        name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center, Zion, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Donald P Braun
               affiliation:
                     name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center
                     address:
                        name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center, Zion, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Brenten Popiel
               affiliation:
                     name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center
                     address:
                        name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center, Zion, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Subhasis Misra
               affiliation:
                     name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center
                     address:
                        name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center, Zion, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Komen C Brown
               affiliation:
                     name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center
                     address:
                        name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center, Zion, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:The relationship between baseline nutritional status with subsequent parenteral nutrition and clinical outcomes in cancer patients undergoing hyperthermic intraperitoneal chemotherapy
      description:The combination of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is a promising treatment option for selected patients with peritoneal carcinomatosis. This retrospective study investigated the relationship between baseline nutritional assessment with subsequent parenteral nutritional (PN) and clinical outcomes in cancer patients undergoing CRS and HIPEC. A consecutive series of 60 patients undergoing CRS and HIPEC at our institution between January 2009 and May 2011. Subjective Global Assessment (SGA) was used to assess nutritional status. Patients were classified preoperatively as: well nourished (SGA-A), mildly-moderately malnourished (SGA-B), and severely malnourished (SGA-C). For PN, patients were divided into 2 groups: those who received PN (PN+) and those who did not receive PN (PN-). The primary outcomes of interest were length of stay (LOS), postoperative complications, ECOG performance status (PS) and survival. LOS was calculated as the number of days in the hospital post surgery. Performance status was measured on a scale of 0-4. Survival was calculated from the date of first visit to the date of death/last contact. Of 60 patients, 19 were males and 41 females. The mean age at presentation was 50.3 years. The most common cancer types were colorectal (n = 24) and gynecologic (n = 19) with the majority of patients (n = 47) treated previously before coming to our institution. 33 patients were SGA-A, 22 SGA-B and 5 SGA-C prior to surgery. Of a total of 60 patients, 31 received PN. Mean LOS for the entire cohort was 16.2 days (SD = 9.8). Mean LOS for preoperative SGA-A, SGA-B and SGA-C were 15.0, 15.2 and 27.8 days respectively (ANOVA p = 0.02). Overall incidence of complications was 26.7% (16/60). Complications were recorded in 9 of 33 (27.3%) preoperative SGA-A patients and 7 of 27 (25.9%) SGA-B + C patients (p = 0.91). The median overall survival was 17.5 months (95% CI = 13.0 to 22.1 months). Median survival for preoperative SGA-A and SGA-B + C cohorts was 22.4 and 10.4 months respectively (p = 0.006). The preoperative SGA predicts LOS and survival in cancer patients undergoing HIPEC. Future randomized clinical trials in this patient population should investigate the systematic provision of PN to all malnourished patients in the preoperative period for a minimum of 7-10 days with the continuation of PN in the postoperative period.
      datePublished:2013-08-14T00:00:00Z
      dateModified:2013-08-14T00:00:00Z
      pageStart:1
      pageEnd:8
      license:https://creativecommons.org/licenses/by/2.0
      sameAs:https://doi.org/10.1186/1475-2891-12-118
      keywords:
         Parenteral Nutritional
         Peritoneal Carcinomatosis
         Nutritional Assessment
         Subjective Global Assessment
         Hyperthermic Intraperitoneal Chemotherapy
         Clinical Nutrition
         Health Promotion and Disease Prevention
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1475-2891-12-118/MediaObjects/12937_2013_Article_693_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1475-2891-12-118/MediaObjects/12937_2013_Article_693_Fig2_HTML.jpg
      isPartOf:
         name:Nutrition Journal
         issn:
            1475-2891
         volumeNumber:12
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Pankaj G Vashi
            affiliation:
                  name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center
                  address:
                     name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center, Zion, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Digant Gupta
            affiliation:
                  name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center
                  address:
                     name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center, Zion, USA
                     type:PostalAddress
                  type:Organization
                  name:Cancer Treatment Centers of America®
                  address:
                     name:Cancer Treatment Centers of America®, Schaumburg, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Carolyn A Lammersfeld
            affiliation:
                  name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center
                  address:
                     name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center, Zion, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Donald P Braun
            affiliation:
                  name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center
                  address:
                     name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center, Zion, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Brenten Popiel
            affiliation:
                  name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center
                  address:
                     name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center, Zion, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Subhasis Misra
            affiliation:
                  name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center
                  address:
                     name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center, Zion, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Komen C Brown
            affiliation:
                  name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center
                  address:
                     name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center, Zion, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Nutrition Journal
      issn:
         1475-2891
      volumeNumber:12
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center
      address:
         name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center, Zion, USA
         type:PostalAddress
      name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center
      address:
         name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center, Zion, USA
         type:PostalAddress
      name:Cancer Treatment Centers of America®
      address:
         name:Cancer Treatment Centers of America®, Schaumburg, USA
         type:PostalAddress
      name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center
      address:
         name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center, Zion, USA
         type:PostalAddress
      name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center
      address:
         name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center, Zion, USA
         type:PostalAddress
      name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center
      address:
         name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center, Zion, USA
         type:PostalAddress
      name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center
      address:
         name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center, Zion, USA
         type:PostalAddress
      name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center
      address:
         name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center, Zion, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Pankaj G Vashi
      affiliation:
            name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center
            address:
               name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center, Zion, USA
               type:PostalAddress
            type:Organization
      name:Digant Gupta
      affiliation:
            name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center
            address:
               name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center, Zion, USA
               type:PostalAddress
            type:Organization
            name:Cancer Treatment Centers of America®
            address:
               name:Cancer Treatment Centers of America®, Schaumburg, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Carolyn A Lammersfeld
      affiliation:
            name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center
            address:
               name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center, Zion, USA
               type:PostalAddress
            type:Organization
      name:Donald P Braun
      affiliation:
            name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center
            address:
               name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center, Zion, USA
               type:PostalAddress
            type:Organization
      name:Brenten Popiel
      affiliation:
            name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center
            address:
               name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center, Zion, USA
               type:PostalAddress
            type:Organization
      name:Subhasis Misra
      affiliation:
            name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center
            address:
               name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center, Zion, USA
               type:PostalAddress
            type:Organization
      name:Komen C Brown
      affiliation:
            name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center
            address:
               name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center, Zion, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center, Zion, USA
      name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center, Zion, USA
      name:Cancer Treatment Centers of America®, Schaumburg, USA
      name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center, Zion, USA
      name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center, Zion, USA
      name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center, Zion, USA
      name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center, Zion, USA
      name:Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center, Zion, USA

External Links {🔗}(140)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

5.07s.

LINK . SPRINGER . COM {}